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Background: Fecal incontinence is a common and severely disabling disorder. For patients with severe fecal
incontinence, surgery may prove to be the only adequate treatment option.
Methods: This study reports on 43 patients that were treated with a prosthetic sphincter system between 2005
and 2009 in three coloproctological centres. Main Outcome Measures: complications, anal pressures before and
after surgery, fecal continence score.
Results: The new artificial sphincter system significantly improves continence but leads to some complications in
clinical practice. After implantation of the device, continence improved significantly (Keller & Jostarndt continence
score 2.6 to 14.3 (P < 0.01)). With the band activated, resting pressure improved significantly as compared to
baseline (10.7 mmHg vs. 66.1 mm Hg, P < 0.01). The same holds for anal sphincter squeeze pressure (32.2 mmHg
versus 85.9 mm Hg, P < 0.01). Complications occurred in 21 patients (48.8%): 10 surgical and 13 technical. Two
patients were affected by both technical and surgical problems. The median time of the occurrence was 3 months
postop. In five patients difficulties arose within the first postoperative month leading to explantation of the device
in three patients. 90% of complications occurred in the first year.
Conclusions: The soft anal band of AMI (AAS), a new artificial anal sphincter, improves severe anal incontinence,
but it must be regarded as a last treatment option to avoid a stoma.
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In adult females, the most frequent cause of fecal incon-
tinence is obstetric trauma [1].
Fecal incontinence is usually an acquired disorder. A
small percentage of cases are congenital disorders, such
as imperforate anus, rectal agenesis, cloacal defects,
myelomeningoceles, and meningoceles [2].
The prevalence of fecal incontinence is difficult to de-
termine because patients are reticent to report the dis-
order. Previous studies estimate the prevalence to be
between 2.2 and 20.7 percent [3-6].
Conservative measures, such as dietary and lifestyle
modifications and pelvic floor exercises are effective in
managing mild symptoms and can also be implemented* Correspondence: matthias.goos@uniklinik-freiburg.de
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reproduction in any medium, provided the orfollowing surgical procedures [2,7,8]. However, surgery is
often the only effective treatment for severe incontinence.
In refractory disease, an artificial sphincter should only
be considered as a last resort as an alternative to a
stoma. Anal sphincter prostheses are strictly mechanical
devices and were first implanted to manage urinary in-
continence in 1973 [9]. Fourteen years later, the Lancet
reported on a modified “scott-sphincter” to treat fecal
incontinence [10]. The main purpose of artificial sphinc-
ters is to mimic the external anal sphincter’s (EAS) abil-
ity to control the passage of faeces through the anus.
They do so with the help of circular, flexible and refill-
able cuffs. Currently, two systems are being implanted:
the Acticon Neosphincter® (Artificial Bowel Sphincter
(ABS)) produced by American Medical Instruments (A.
M.S., USA) and the Soft Anal Band System produced by
Agency for Medical Innovations (A.M.I., Austria).
The Artificial Anal Sphincter (AAS) from A.M.I. is
similarly designed to the one of AMS (ABS). The AAS istd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.





inborne / acquired sphincter defect 17 11 6
birth trauma (6x), state after previous surgery
(9×): sphincter or pelvic floor repair, rectopexy,
hemorrhoidectomy, etc.
sequelae after rectal surgery: 8 3 5




neuogenetic 6 5 1
neuroborreliosis, herniated disc, spina bifida,
incomplete spinal cord injury, encephalitis
disseminata, lesion of pudendal nerve
pelvic / pelvic floor trauma (road accident) 3 3
Other 3 2 1
scleroderma (2×), irradiation of prostate cancer
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which are all connected by silicone tubes (Figure 1).
When pressure is applied to the balloon by the patient, the
fill-liquid moves from the balloon to the band and contin-
ence is achieved. To open the sphincter for defecation, the
patient presses on the valve, the fill-liquid moves from the
band to the balloon leaving the sphincter open. The con-
nection between the valve and the subcutaneous safe punc-
ture port (semi-automatic pump), which is placed lateral to
the iliac crest, permits accurate adjustment of the amount
of liquid inside the system (Figure 1). The aim of the study
was to determine the effects of the implant on the fecal in-
continence and surgical complication rates.
Methods
At three different coloproctological centres, 43 patients
with Grade III fecal incontinence (FI) received a Soft
Anal Band System (AAS; Agency for Medical Innovation
(AMI), Feldkirch (Austria), CE Body Number (0297) ID:
170530317; Reg. No. 066924 MR2).
Our patient sample included 43 patients, 16 men (average
age 54 years; SD 17.6) and 27 women (average age 62 years,
SD 9.7). The causes of FI were hereditary (anal atresia) or
acquired sphincter defects (mostly due to a trauma), and the
sequelae of rectal surgery (see: Table 1). Before surgery
all patients were affected by Grade III fecal incontinence (FI)
(mean KJCS 2.6 (SD2.3)). Mean follow-up time was
32.3 months (range 1 – 58; SD16.9).
Preconditions for implantation of an artificial sphincter
were that all other therapeutic options had failed, that
the soft tissues around the anus were intact and patient
compliance was adequate. Contraindications were chronicFigure 1 Components of the soft anal band system ®. P: calibration
port, V: valve, B: balloon / activator, C: cuff ring.inflammatory bowel syndromes, therapy-resistant diarrhoea,
irrigation therapy, receptive anal intercourse, pregnancy, in-
verse acne, tight (fibrotic) anal canal and psychiatric disor-
ders. Anal or rectal prolapse was treated prior to artificial
sphincter implantation. The data were collected prospect-
ively at each centre. The following outcome variables were
recorded: complications: major surgical complications such
as infection, bleeding, penetration and technical problems
such as impaired function of the implant, handling prob-
lems. Patient surveillance was carried out locally at the re-
spective centres based on local surveillance standards. The
prosthesis was viewed as the last treatment option before
the formation of a definitive stoma. All patients gave in-
formed consent. Continence was measured with a standard-
ized questionnaire (Keller & Jostarndt continence score
(KJCS)) [11]. The score consists of 10 items, which are
scaled from 0 to 6 points. The total score has a range of 36–
0 points. The scale is divided into ranges to indicate four dif-
ferent degrees of continence (see Table 2). A score between
11 and 0 corresponds to Grade III incontinence.
The KJC scores were calculated before the operation and
at the time of activation of the device. Anal resting and
squeeze pressures (RP / SP) were measured using a water-
filled pressure sensor that was connected to a handheld de-
vice designed to display and record values (Sphinctometer:
STM-0169-SM, smProMedico, Aachen, Germany).
Measurements were recorded before surgery and at
the time of system activation. Readings were taken for
the filled (active) and relaxed (inactive) anal band.
Statistical analysis was performed with STATA® 11.0
statistical packages.
Table 2 Keller & Jostarndt continence score (KJCS)
Symptom 0 point 1 point 2 points
frequency > 3 per day 2-3 per day 0 - 1 per day
consistency predominant liquid predominant mushy perdominant solid
perception of urgency regularly none or too late uncertain always just in time or certain
lead time none seconds minutes
discrimination (gaseous, liquid, solid) none uncertain certain
care needs always occasional none
Symptom 0 point 3 points 6 points
soiling always occasional none
incontinence: gas always occasional none
incontinence: liquid always occasional none
incontinence: solid always occasional none
total score
36 – 31 points 30 – 24 23-12 11 - 0
grade 0 grade I grade II grade III
complete continent little contamination gross contamination complete incontinence
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Currently, two systems are being implanted: the Acticon
Neosphincter® (Artificial Bowel Sphincter (ABS)) pro-
duced by American Medical Instruments (A.M.S., USA)
and the Soft Anal Band System produced by Agency for
Medical Innovations (A.M.I., Austria).
The Artificial Anal Sphincter (AAS) from A.M.I. is
similarly designed to the one of AMS (ABS). The AAS is
implanted subcutaneously and consists of four parts,
which are all connected by silicone tubes: 1.) the Soft
Anal Band made of silicone (available in three sizes, plus
two extension parts, also available in two different sizes),
2.) a silicone-bonded valve to control the fill-liquid of
the system, 3.) a manually operated silicone balloon (ac-
tivator) to move the fill-liquid into the band to close the
sphincter, and 4.) a titanium port with anti-kink protec-
tion for individual adjustment of the fill volume. When
pressure is applied to the balloon by the patient, the fill-
liquid moves from the balloon to the band and contin-
ence is achieved. To open the sphincter for defecation,
the patient presses on the valve, the fill-liquid moves
from the band to the balloon leaving the sphincter open.
The connection between the valve and the subcutaneous
safe puncture port (semi-automatic pump), which is
placed lateral to the iliac crest, permits accurate adjust-
ment of the amount of liquid inside the system (Figure 1).
Surgery
All patients received bowel preparation and prophylactic
antibiotics before surgery. Patients were placed in the
lithotomy position, and skin incision lines were marked
by the surgeon according to anatomical landmarks andaccording to the chosen implantation position (Figure 2).
After bilateral incision 3–4 cm from the anocutaneous
line, a circumferential, subcutaneous pocket is created
by dissection of the ischiorectal space.
The size of the anal band was either estimated or mea-
sured with a tape measure. After positioning the anal band,
the connecting tube to the valve was placed subcutane-
ously from the perianal region to the lower abdominal wall.
The perianal wounds were closed with sutures in double
layer technique or sealed with histoacrylic glue.
The tube from the band connects on one side of the
valve. The activator and the port are also connected to
the valve. Once in situ, the system was deflated and then
filled with a defined mixture of 18 ml distilled water and
radio-opaque solution. The system was now checked for
function and leakage. Anal band function was tested
manometrically and digitally and then left in the open
position for 5–6 weeks to allow for healing.
Valve, activator and port were fixed with PDS 2/0 to the
underlying fascia. After five to six weeks, patients were
instructed on how to activate the Soft Anal Band System.
This observational study was approved by the ethics
committee of the university hospital of Freiburg (No.
437/129).
Results
Anal pressure values changed significantly after the op-
eration. On average 10.7 mmHg (SD8.3) was measured
for resting pressure, and 32.2 mmHg (SD21.6) for
squeeze pressure.
After surgery, continence improved significantly (KJCS
2.6 (SD2.3) to 14.3 (SD2.7), P < 0.01).
Figure 2 Two possible implantation sites for the system’s components. The implant positions must be discussed with the patient and
accessability and operation of the elements has to be simulated. A: The balloon (activator), port and valve are placed on the right side of the
abdomen through a single portal. The valve is placed right above the iliac crest, the activator (balloon) over the fascia of the abdominal muscles
in the subcutaneous tissue. The port is positioned for easy access through a puncture in the subcutaneous tissue. B: Two incisions in the right
and left lower abdomen: Activator (balloon) and valve are placed above the contralateral iliac crest. The port is placed close to the valve in the
subcutaneous tissue.
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nificantly as compared to baseline (10.7 (SD8.3) vs. 66.1
(SD14.3), P < 0.01). The same holds for squeeze pressure
(32.2 (SD21.6) vs 85.9 (SD21.4), P < 0.01). Inactivation of
the band led to a significant drop in pressure values: 66.1
(SD14.3) vs. 16.9 (SD6.2) (P < 0.01) for resting pressure,
85.9 (SD21.4) vs 40.7 (SD17.0) (P < 0.01) for squeeze pres-
sure (see Table 3).
Surgical outcome
Complications occurred in 21 cases (48.8%): 10 surgical and
13 technical problems (failure of prosthetic components or
failure related to handling) occurred. Two patients were
affected by both technical and surgical problems. The me-
dian period for complications was 3 months. 5 times there
were early problems within the first month: leading in 3
cases (infection 2×; perforation of device 1×) to the removal
of the devices. 90% of the problems occurred in the first
year. In 9 patients (21%) the system had to be explanted due
to infection (4×), perforation (1×), tumor recurrence (1×),
rectovesical fistula (1×), ineffective treatment (1×) or pain
(1×). In 3 of theses patients (1× perforation, 2× infection)
the system was re-implanted successfully and without fur-
ther complications.
10 Revisions of the device were necessary due to failure
of the valve (8×) and failure of the anal band (2 ×). In all
cases the affected components were replaced. Two pa-
tients had to be treated repeatedly due to valve failures.In 4 patients revisions where necessary due to devel-
opment of a fibrotic capsule (1 ×); weight gain (1× - >
transposition of the device); pain (1×); bleeding after
activation of the device occurred once under oral
anticoagulation. In all cases the affected implant site was
surgically revised, the implants were retained.
Two patients were unable to operate the valve by them-
selves. Close relatives had to help in handling the valves.
Discussion
In discussing the results, one must bear in mind that
prosthetic sphincters are the last therapeutic option in
the treatment of severe fecal incontinence before a
stoma is created. A stoma is for many patients a source
of significant psychological distress. In order to avoid a
stoma, these patients are willing to live with an artificial
implant, which may only improve their symptoms
slightly. In the study present 43 patients were treated
with a new artificial bowel sphincter and prospectively
examined over 32 month on average. The AAS elevates
anal pressure values significantly from 11 to 66 mmHg
for the resting pressure and 32 to 85 mmHg for the
squeezing pressure respectively. Although many patients
are still significantly incontinent, the condition is less
severe. KJC-Scores improved from 3 to 14, which corre-
sponds to an FI grade II.
The modest prospects of treatment must be given to
the patient.
Table 3 Anal resting and squeezing pressures before and after surgery
Baseline Pressures at the time of activation P
Filled cuff Relaxed cuff
resting pressure (SD) [mmHg] 10.70 (8.32) 66.10 (14.27) 16.93 (6.15) (*)
squeezing pressure (SD) [mmHg] 32.21 (21.58) 85.91 (21.44) 40.65 (17.03) (*)
(*) All differences between the mean values were highly significant at P < 0.01.
(*) Baseline: value before the operation.
(*) Time of activation = 5–6 week after the operation.
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AMI Soft Anal Band system (AAS) should be compared
with the current published results for the best investi-
gated artificial sphincter system for fecal incontinence,
namely, ABS Neosphincter®. With respect to wound in-
fection and penetration rates our study provided some
initial indications: Wound infection rate was 9% (4 out
of 43 patients), which is in the lower range compared to
the reported rates for the Acticon Neosphincter® [12-23].
In the population of our study, only 1 of 43 treated pa-
tients experienced a penetration of the Soft Anal cuff ring
into the rectum. For the Neosphincter penetration rates
up to 25% are described [18,23]. Overall the prosthesis
had to be removed in 9 cases (21%) for various reasons
and was successfully re-implanted in three cases. In eight
cases revisions were necessary to deal with a dysfunctional
valve. These complications occurred mainly during the
initial implantation procedures between 2005 and 2006.
Experience with the system and technical modifications of
the valve by the manufacturer reduced those particular
problems. Nevertheless, handling the manually operated
parts of the system, especially the valve, remained a prob-
lem for the patients and two patients needed constant
support from their relatives. The systems are designed to
be operated through the patient’s abdominal wall, which
may be thick in the obese patient. A balloon the size of aFigure 3 Valve after revision (right hand side) compared to the old otangerine has to be pressed together through the fatty tis-
sue of the abdominal wall and this action may be painful
and may cause the activator to shift, slip or distort. The
valve cannot be positioned on a bony support for func-
tional reason, therefore, the fascia and the tensed abdom-
inal wall are the only mechanisms of counter pressure.
The valve’s pressure point is less than 1 cm2, which is very
small and not easily located. This small pressure point
must be accurately depressed through a layer of cutis
and subcutaneous tissue and a large force applied to
open the valve, which requires good hand-valve coord-
ination and considerable aptitude on the part of the pa-
tient. Reduction of the subcutaneous tissue above the
valve can bring relief. The manufacturer is aware of this
biomechanical problem and a valve revision was re-
leased in 2011 (Figure 3).Limitations
The study is of descriptive nature. The results reflect the
experiences with this new artificial bowel sphincter de-
vice. The data were collected uniformly and prospect-
ively. Although the results are compared with published
data for the well-studied Neosphincter, general state-
ments can not be made about an advantage or inferiority
of the AAS.ne (left side).
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Innovative sphincter prosthesis has now become avail-
able in the form of the soft anal band system (AAS). In-
fections and penetration rates are comparatively low.
Handling the valve is the main product-related difficulty,
whereby the product manual does provide adequate in-
structions. The AAS improves incontinence, but it must
be regarded as a last surgical treatment option to avoid a
stoma. Preliminary results show a considerable compli-
cation rate with wound infections in four and band per-
foration / penetration in one patient. Explantation of the
device was necessary in a total of 9 out of 43 patients.
Technical problems relating to valve handling or sys-
tem failure should be addressed in the design of the
improved second generation Soft Anal Band System
(AAS). The manufacturer released a new version of the
valve in 2011.
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